Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Newborn Screening Market, by Product Type
1.4.2 Europe Newborn Screening Market, by Test Type
1.4.3 Europe Newborn Screening Market, by End User
1.4.4 Europe Newborn Screening Market, by Technology
1.4.5 Europe Newborn Screening Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition & scenarios
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Newborn Screening Market
Chapter 4. Europe Newborn Screening Market by Product Type
4.1 Europe Consumables Market by Country
4.2 Europe Instrument Market by Country
Chapter 5. Europe Newborn Screening Market by Test Type
5.1 Europe Blood Test Market by Country
5.2 Europe Hearing Screening Test Market by Country
5.3 Europe Heart screening Market by Country
Chapter 6. Europe Newborn Screening Market by End User
6.1 Europe Hospitals Market by Country
6.2 Europe Clinical Laboratories Market by Country
Chapter 7. Europe Newborn Screening Market by Technology
7.1 Europe Tandem Mass Spectrometry (TMS) Market by Country
7.2 Europe Molecular Assays Market by Country
7.3 Europe Immunoassays & Enzymatic Assays Market by Country
7.4 Europe Hearing Screen Technology Market by Country
7.5 Europe Pulse Oximetry Screening Technology Market by Country
7.6 Europe Others Market by Country
Chapter 8. Europe Newborn Screening Market by Country
8.1 Germany Newborn Screening Market
8.1.1 Germany Newborn Screening Market by Product Type
8.1.2 Germany Newborn Screening Market by Test Type
8.1.3 Germany Newborn Screening Market by End User
8.1.4 Germany Newborn Screening Market by Technology
8.2 UK Newborn Screening Market
8.2.1 UK Newborn Screening Market by Product Type
8.2.2 UK Newborn Screening Market by Test Type
8.2.3 UK Newborn Screening Market by End User
8.2.4 UK Newborn Screening Market by Technology
8.3 France Newborn Screening Market
8.3.1 France Newborn Screening Market by Product Type
8.3.2 France Newborn Screening Market by Test Type
8.3.3 France Newborn Screening Market by End User
8.3.4 France Newborn Screening Market by Technology
8.4 Russia Newborn Screening Market
8.4.1 Russia Newborn Screening Market by Product Type
8.4.2 Russia Newborn Screening Market by Test Type
8.4.3 Russia Newborn Screening Market by End User
8.4.4 Russia Newborn Screening Market by Technology
8.5 Spain Newborn Screening Market
8.5.1 Spain Newborn Screening Market by Product Type
8.5.2 Spain Newborn Screening Market by Test Type
8.5.3 Spain Newborn Screening Market by End User
8.5.4 Spain Newborn Screening Market by Technology
8.6 Italy Newborn Screening Market
8.6.1 Italy Newborn Screening Market by Product Type
8.6.2 Italy Newborn Screening Market by Test Type
8.6.3 Italy Newborn Screening Market by End User
8.6.4 Italy Newborn Screening Market by Technology
8.7 Rest of Europe Newborn Screening Market
8.7.1 Rest of Europe Newborn Screening Market by Product Type
8.7.2 Rest of Europe Newborn Screening Market by Test Type
8.7.3 Rest of Europe Newborn Screening Market by End User
8.7.4 Rest of Europe Newborn Screening Market by Technology
Chapter 9. Company Profiles
9.1 General Electric (GE) Co. (GE Healthcare)
9.1.1 Company Overview
9.1.1 Financial Analysis
9.1.2 Segmental and Regional Analysis
9.1.3 Research & Development Expense
9.1.4 Recent strategies and developments:
9.1.4.1 Acquisition and Mergers:
9.1.5 SWOT Analysis
9.2 F. Hoffmann-La Roche Ltd.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.3 Bio-Rad laboratories, Inc.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expenses
9.4 Natus Medical Incorporated
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Regional & Segmental Analysis
9.4.4 Research & Development Expenses
9.4.5 Recent strategies and developments:
9.4.5.1 Partnerships, Collaborations, and Agreements:
9.4.5.2 Acquisition and Mergers:
9.5 Masimo Corporation
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Regional Analysis
9.5.4 Research & Development Expense
9.5.5 Recent strategies and developments:
9.5.5.1 Product Launches and Product Expansions:
9.5.5.2 Approvals and Trials:
9.6 Waters Corporation
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expense
9.7 PerkinElmer, Inc.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expense
9.7.5 Recent strategies and developments:
9.7.5.1 Approvals and Trials:
9.8 AB Sciex LLC (Danaher Corporation)
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expense
9.9 Medtronic PLC (Covidien plc)
9.9.1 Company overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expenses
9.9.5 SWOT Analysis
9.10. Trivitron Healthcare Pvt. Ltd.
9.10.1 Company Overview
Unique Offerings 